These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26871475)

  • 1. Honokiol bis-dichloroacetate (Honokiol DCA) demonstrates activity in vemurafenib-resistant melanoma in vivo.
    Bonner MY; Karlsson I; Rodolfo M; Arnold RS; Vergani E; Arbiser JL
    Oncotarget; 2016 Mar; 7(11):12857-68. PubMed ID: 26871475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
    Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
    Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kuete V; Kadioglu O; Börtzler J; Khalid H; Greten HJ; Efferth T
    Phytomedicine; 2014 Oct; 21(12):1525-33. PubMed ID: 25442261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic Effects of Honokiol on Melanoma.
    Guillermo-Lagae R; Santha S; Thomas M; Zoelle E; Stevens J; Kaushik RS; Dwivedi C
    Biomed Res Int; 2017; 2017():5496398. PubMed ID: 28194418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
    Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM
    Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Honokiol, an Active Compound of Magnolia Plant, Inhibits Growth, and Progression of Cancers of Different Organs.
    Prasad R; Katiyar SK
    Adv Exp Med Biol; 2016; 928():245-265. PubMed ID: 27671820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol.
    Luo Y; Xu Y; Chen L; Hu J; Peng C; Xie D; Shi J; Huang W; Xu G; Peng M; Han J; Li R; Yang S; Wei Y
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4702-5. PubMed ID: 19589678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
    Hahm ER; Arlotti JA; Marynowski SW; Singh SV
    Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
    Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
    Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress.
    Chen YJ; Wu CL; Liu JF; Fong YC; Hsu SF; Li TM; Su YC; Liu SH; Tang CH
    Cancer Lett; 2010 May; 291(1):20-30. PubMed ID: 19880244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
    Zubrilov I; Sagi-Assif O; Izraely S; Meshel T; Ben-Menahem S; Ginat R; Pasmanik-Chor M; Nahmias C; Couraud PO; Hoon DS; Witz IP
    Cancer Lett; 2015 May; 361(1):86-96. PubMed ID: 25725450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells.
    Lu CH; Chen SH; Chang YS; Liu YW; Wu JY; Lim YP; Yu HI; Lee YR
    Pharmacol Res; 2017 Jan; 115():288-298. PubMed ID: 27940017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Honokiol induces cell cycle arrest and apoptosis via inhibition of survival signals in adult T-cell leukemia.
    Ishikawa C; Arbiser JL; Mori N
    Biochim Biophys Acta; 2012 Jul; 1820(7):879-87. PubMed ID: 22465179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rescue of cell cycle progression in BRAF
    Toress-Collado AX; Nazarian R; Jazirehi AR
    Tumour Biol; 2017 Sep; 39(9):1010428317721620. PubMed ID: 28936920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore.
    Li L; Han W; Gu Y; Qiu S; Lu Q; Jin J; Luo J; Hu X
    Cancer Res; 2007 May; 67(10):4894-903. PubMed ID: 17510419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of honokiol-induced intracellular Ca(2+) rises and apoptosis in human glioblastoma cells.
    Liang WZ; Chou CT; Chang HT; Cheng JS; Kuo DH; Ko KC; Chiang NN; Wu RF; Shieh P; Jan CR
    Chem Biol Interact; 2014 Sep; 221():13-23. PubMed ID: 25106108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition.
    Trotta AP; Gelles JD; Serasinghe MN; Loi P; Arbiser JL; Chipuk JE
    J Biol Chem; 2017 Jul; 292(28):11727-11739. PubMed ID: 28546431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule Polyphenol.
    Pearson HE; Iida M; Orbuch RA; McDaniel NK; Nickel KP; Kimple RJ; Arbiser JL; Wheeler DL
    Mol Cancer Ther; 2018 Jan; 17(1):204-214. PubMed ID: 29054984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.